Occurrence patterns of pharmaceuticals in water and wastewater environments

The occurrence of pharmaceuticals and their metabolites and transformation products in the environment is becoming a matter of concern, because these compounds, which may have adverse effects on living organisms, are extensively and increasingly used in human and veterinary medicine and are released continuously into the environment. A variety of pharmaceuticals have been detected in many environmental samples worldwide. Their occurrence has been reported in sewage-treatment-plant effluents, surface water, seawater, groundwater, soil, sediment and fish. This paper provides an overview of recent scientific research on the sources, occurrence, and fate of pharmaceuticals in water and wastewater.     

Occurrence of pharmaceutical metabolites and transformation products in the aquatic environment of the Mediterranean area

The presence of pharmaceutically active substances (PhACs) in aquatic ecosystems is of great concern due to their constant occurrence in different water systems and potential negative effects on the quality of water and living organisms. After consumption, PhACs are excreted as the parent compound, and/or as free or conjugated metabolites, which might finally arrive to surface and ground waters after their incomplete removal (and possible degradation) in the wastewater treatment plants (WWTP). A large amount of data about parent PhACs in water has been reported in the literature in the last decade; however, there is a lack of information about the presence of their metabolites and transformation/degradation products (TPs). Recent publications report that PhACs found in water are only the “top of the iceberg” in relation to the environmental impact associated to the consumption of PhACs. From a scientific-technological point of view, the overall study of PhACs is a challenge and requires to advance with respect to current knowledge and analytical capacities, considering several key aspects, such as the reliable identification and quantification of the compounds, the improvement of the removal efficiency by the WWTPs, the study of their behaviour in the environment (e.g. persistence and biodegradability), and the environmental risk assessment, considering not only the parent PhACs but also their transformation/metabolism products. In this work, it is intended to delve into this problem, presenting a detailed overview on metabolites and TPs of PhACs in environmental waters from the Mediterranean area. Analytical and environmental problems associated to the determination of these compounds are briefly commented, ending the paper with the main conclusions and expected future trends in relation to this field.     

Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research

Pollution from pharmaceuticals in the aquatic environment is now recognized as an environmental concern in many countries. This has led to the creation of an extensive area of research, including among others: their chemical identification and quantification; elucidation of transformation pathways when present in wastewater-treatment plants or in environmental matrices; assessment of their potential biological effects; and development and application of advanced treatment processes for their removal and/or mineralization. Pharmaceuticals are a unique category of pollutants, because of their special characteristics, and their behavior and fate cannot be simulated with other chemical organic contaminants. Over the last decade the scientific community has embraced research in this specific field and the outcome has been immense. This was facilitated by advances in chromatographic techniques and relevant biological assays. Despite this, a number of unanswered questions exist and still there is much room for development and work towards a more solid understanding of the actual consequences of the release of pharmaceuticals in the environment. This review tries to present part of the knowledge that is currently available with regard to the occurrence of pharmaceutical residues in aquatic matrices, the progress made during the last several years on identification of such compounds down to trace levels, and of new, previously unidentified, pharmaceuticals such as illicit drugs, metabolites, and photo-products. It also tries to discuss the main recent findings in respect of the capacity of various treatment technologies to remove these contaminants and to highlight some of the adverse effects that may be related to their ubiquitous existence. Finally, socioeconomic measures that may be able to hinder the introduction of such compounds into the environment are briefly discussed.     

Prediction of drug metabolites using neural machine translation

Metabolic processes in the human body can alter the structure of a drug affecting its efficacy and safety. As a result, the investigation of the metabolic fate of a candidate drug is an essential part of drug design studies. Computational approaches have been developed for the prediction of possible drug metabolites in an effort to assist the traditional and resource-demanding experimental route. Current methodologies are based upon metabolic transformation rules, which are tied to specific enzyme families and therefore lack generalization, and additionally may involve manual work from experts limiting scalability. We present a rule-free, end-to-end learning-based method for predicting possible human metabolites of small molecules including drugs. The metabolite prediction task is approached as a sequence translation problem with chemical compounds represented using the SMILES notation. We perform transfer learning on a deep learning transformer model for sequence translation, originally trained on chemical reaction data, to predict the outcome of human metabolic reactions. We further build an ensemble model to account for multiple and diverse metabolites. Extensive evaluation reveals that the proposed method generalizes well to different enzyme families, as it can correctly predict metabolites through phase I and phase II drug metabolism as well as other enzymes. Compared to existing rule-based approaches, our method has equivalent performance on the major enzyme families while it additionally finds metabolites through less common enzymes. Our results indicate that the proposed approach can provide a comprehensive study of drug metabolism that does not restrict to the major enzyme families and does not require the extraction of transformation rules.

The structure of the drug, represented with a SMILES sequence, is being translated into the structures of possible metabolites that can be formed in the human body.     

Analytical methodologies for the determination of nitroimidazole residues in biological and environmental liquid samples: A review

Nitroimidazoles (NDZs) are antiprotozoal drugs that are typically used in veterinary and human medicine. NDZs and their metabolites are believed to possess genotoxic, carcinogenic and mutagenic properties, and this is (one reason) why their use has been banned within the European Union. Hence, the determination of trace residues of these substances in edible animal tissues has been of growing concern over the past few years. Even, though there has been a need to develop sensitive and reliable analytical methods to study the residues of these compounds in different matrices, available methodologies in environmental samples are rather limited. These and other pharmaceutical compounds have become one of the most important new classes of environmental pollutants that have been detected in wastewater-treatment-plant (WWTP) effluents, receiving waters, drinking water and groundwater. A compilation of the most representative analytical methodologies for the determination of NDZ residues during the last decade is presented in this paper. Its scope is the two main areas which require their determination, namely biological and environmental matrices. A detailed explanation of both areas, including sample treatment and detection systems, and future trends is presented, focusing on the difficulties of confirming analytes at low concentration levels.     

Determination of non-steroidal anti-inflammatory drugs in environmental samples by chromatographic and electrophoretic techniques

Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of pharmaceutical compounds widely used in human health care and often found in the aquatic environment, with their metabolites. After an introduction that describes the general problem of drug contamination, the properties of NSAIDs, and environmental risk assessment, this review surveys the chromatographic and electrophoretic methods of analysis in use today for monitoring the most important representatives of this pharmaceutical class in different environmental samples.     

加速溶剂萃取-分子筛固相萃取-气相色谱-串联质谱法测定土壤中多氯萘北大核心CSCD

新污染物引发的环境和健康风险正逐步受到社会各界的广泛关注,我国第十四个五年规划和2035年远景目标纲要明确“重视新污染物治理”。作为新型的持久性有机污染物,多氯萘(PCNs)在土壤中通常处于痕量水平,一般需要经过多层硅胶柱/氧化铝柱等复杂的净化方法,再结合有效的分析手段才能实现准确测定。关注土壤中多氯萘分离分析方法可以为掌握和监管其在土壤中的污染状况提供技术和方法支持。研究以13X分子筛作为固相萃取吸附剂,评价了其对多氯萘的净化效果。研究发现:使用正己烷作为上样溶剂和淋洗剂,10 mL二氯甲烷/正己烷(2∶15,v/v)为洗脱溶剂,可以实现PCNs与脂类大分子等干扰物的选择性分离,且多氯萘内标的平均回收率为56.1%~88.0%。与凝胶渗透色谱法、弗罗里硅土固相萃取柱以及多层硅胶柱/氧化铝柱相比,13X分子筛对土壤提取液的净化效果优于前两种净化方法,可以获得与多层硅胶/氧化铝柱相近的净化效果(53.0%~117.0%),而且操作更加简单,环境更加友好,分析成本大幅度下降。在此基础之上,建立了加速溶剂萃取-分子筛固相萃取,结合气相色谱-三重四极杆质谱法测定土壤中PCNs的分析方法。PCNs同族体的方法检出限为0.009~0.6 ng/g。采用基质加标法评价了本方法的精密度和准确度,CN-3、13、42、46、52、53、73、75在低、中、高加标水平下的平均加标回收率分别为70%~128%、71%~115%和61%~114%,测定结果的相对标准偏差分别为4.2%~23%、6.5%~31%和4.7%~22%,满足痕量分析的要求且平行性较好。从整个分析流程来看,13X分子筛有望成为新污染物净化的新型固相萃取吸附剂,并在土壤新污染物普查中发挥重要作用。     

Occurrence of pharmaceuticals and their metabolites in sewage sludge and soil: A review on their distribution and environmental risk assessment

The recycling and recovery of organic matter and nutrients from sewage sludge for application in agricultural soils is gaining interest, while the presence of pharmaceutically active compounds (PhACs) in this matrix may have a great impact on the environment and human health. The aim of this review paper is to outline recent research on the occurrence of PhACs and their metabolites in sewage treatment lines. A total of 32 classes of therapeutic groups including 180 PhACs and 45 metabolites have been included. In a first part, a summary of the analytical methods with a critical overview of the extraction and determination techniques, quality control issues and methodological challenges for their determination is included. Subsequently, the study gives a snapshot of the concentration levels and distribution patterns found in primary, secondary, digested (aerobically and anaerobically), dehydrated and composted sludge. Data have been systematically summarized and categorized according to matrix type, treatment processes available for PhAC degradation in sludge, and geographical areas. Our literature review showed that antimicrobials, antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), antidepressants and antidiabetics were the most abundant PhACs found in sludge matrices.Overall, attenuation of PhACs concentrations occurs during sludge stabilization, in particular during anaerobic digestion and composting. PhAC sorption onto sludge is strongly affected by the physicochemical properties, the sludge matrix and the operating and environmental conditions. Lastly, the paper discusses the impact of PhACs on sludge-amended agricultural land. The potential ecotoxicological risk associated with the presence of PhACs in amended soil is medium-low for most PhACs. The most critical compounds found in sludge-amended soil are ciprofloxacin, 17α-ethinylestradiol, 17β-estradiol, and triclocarban and triclosan.     

Grapevine as a Rich Source of Polyphenolic Compounds

Grapes are rich in primary and secondary metabolites. Among the secondary metabolites, polyphenolic compounds are the most abundant in grape berries. Besides their important impacts on grape and wine quality, this class of compounds has beneficial effects on human health. Due to their antioxidant activity, polyphenols and phenolic acids can act as anti-inflammatory and anticancerogenic agents, and can modulate the immune system. In grape berries, polyphenols and phenolic acids can be located in the pericarp and seeds, but distribution differs considerably among these tissues. Although some classes of polyphenols and phenolic acids are under strict genetic control, the final content is highly influenced by environmental factors, such as climate, soil, vineyard, and management. This review aims to present the main classes of polyphenolic compounds and phenolic acids in different berry tissues and grape varieties and special emphasis on their beneficial effect on human health.